Role of cytokines in mediating mechanical hypernociception in a model of delayed-type hypersensitivity in mice

European Journal of Pain

Volumn 12, Issue 8, 2008, Pages 1059-1068

  Cunha, Thiago M ^a   Verri Jr , Waldiceu A ^a   Valério, Daniel A ^a   Guerrero, Ana T ^a   Nogueira, Luciana G ^a   Vieira, Silvio M ^a   Souza, Danielle G ^b   Teixeira, Mauro M ^b   Poole, Stephen ^c   Ferreira, Sergio H ^a   Cunha, Fernando Q ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Cytokines; Delayed type hypersensitivity; Hyperalgesia; Hypernociception; Inflammatory pain; TNF

Indexed keywords

BOVINE SERUM ALBUMIN; CXCL1 CHEMOKINE; GUANETHIDINE; INDOMETACIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; POLYPROPYLENE; PROSTANOID; PROTEIN INHIBITOR; REPARIXIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; FLEXOR REFLEX; FORCE TRANSDUCER; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

ANIMALS; CHEMOKINE CXCL1; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HYPERALGESIA; HYPERSENSITIVITY, DELAYED; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROIMMUNOMODULATION; NOCICEPTORS; PAIN MEASUREMENT; PAIN THRESHOLD; PHYSICAL STIMULATION; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 50849125118     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2008.02.003     Document Type: Article

References (36)

1. Brackertz D., Mitchell G.F., and Mackay I.R. Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum 20 (1977) 841-850
2. Canetti C., Silva J.S., Ferreira S.H., and Cunha F.Q. Tumour necrosis factor-alpha and leukotriene B(4) mediate the neutrophil migration in immune inflammation. Brit J Pharmacol 134 (2001) 1619-1628
3. Chabaud M., Durand J.M., Buchs N., Fossiez F., Page G., Frappart L., et al. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42 (1999) 963-970
4. Cher D.J., and Mosmann T.R. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J Immunol 138 (1987) 3688-3694
5. Cook A.D., Braine E.L., and Hamilton J.A. The phenotype of inflammatory macrophages is stimulus dependent: implications for the nature of the inflammatory response. J Immunol 171 (2003) 4816-4823
6. Cunha F.Q., Poole S., Lorenzetti B.B., and Ferreira S.H. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Brit J Pharmacol 107 (1992) 660-664
7. Cunha J.M., Sachs D., Canetti C.A., Poole S., Ferreira S.H., and Cunha F.Q. The critical role of leukotriene B4 in antigen-induced mechanical hyperalgesia in immunised rats. Brit J Pharmacol 139 (2003) 1135-1145
8. Cunha T.M., Verri Jr. W.A., Vivancos G.G., Moreira I.F., Reis S., Parada C.A., et al. An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res 37 (2004) 401-407
9. Cunha T.M., Verri Jr. W.A., Silva J.S., Poole S., Cunha F.Q., and Ferreira S.H. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci USA 102 (2005) 1755-1760
10. Cunha T.M., Verri Jr. W.A., Fukada S.Y., Guerrero A.T., Santodomingo-Garzon T., Poole S., et al. TNF-alpha and IL-1beta mediate inflammatory hypernociception in mice triggered by B(1) but not B(2) kinin receptor. Eur J Pharmacol 573 (2007) 221-229
11. Cunha T.M., Verri Jr. W.A., Poole S., Parada C.A., Cunha F.Q., and Ferreira S.H. Pain facilitation by proinflammatory cytokine actions at peripheral nerve terminals. In: DeLeo J., Sorkin L., and Watkins L. (Eds). Immune and glial regulation of pain vol. 1 (2008), IASP Press, Seattle 67-83
12. Dunn C.J., Gibbons A.J., and Miller S.K. Development of a delayed-type hypersensitivity granuloma model in the mouse for the study of chronic immune-mediated inflammatory disease. Agents Actions 27 (1989) 365-368
13. 2+ dependent process. Prostaglandins 18 (1979) 179-190
14. Ferreira S.H., Lorenzetti B.B., Bristow A.F., and Poole S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 334 (1988) 698-700
15. Khasar S.G., McCarter G., and Levine J.D. Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol 81 (1999) 1104-1112
16. Koenders M.I., Joosten L.A., and van den Berg W.B. Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis. Ann Rheum Dis. 65 Suppl. 3 (2006) iii29-iii33 November
17. Kondo S., and Sauder D.N. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation. Eur J Immunol 27 (1997) 1713-1718
18. Langrish C.L., McKenzie B.S., Wilson N.J., de Waal Malefyt R., Kastelein R.A., and Cua D.J. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 202 (2004) 96-105
19. Lorenzetti B.B., Veiga F.H., Canetti C.A., Poole S., Cunha F.Q., and Ferreira S.H. Cytokine-induced neutrophil chemoattractant 1 (CINC-1) mediates the sympathetic component of inflammatory mechanical hypersensitivity in rats. Eur Cytokine Network 13 (2002) 456-461
20. Nakamura M., and Ferreira S.H. A peripheral sympathetic component in inflammatory hyperalgesia. Eur J Pharmacol 135 (1987) 145-153
21. Pfeffer K., Matsuyama T., Kundig T.M., Wakeham A., Kishihara K., Shahinian A., et al. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73 (1993) 457-467
22. Rankin E.C., Choy E.H., Kassimos D., Kingsley G.H., Sopwith A.M., Isenberg D.A., et al. The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis. Brit J Rheumatol 34 (1995) 334-342
23. Safieh-Garabedian B., Poole S., Allchorne A., Winter J., and Woolf C.J. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Brit J Pharmacol 115 (1995) 1265-1275
24. Schaible H.G., Ebersberger A., and Von Banchet G.S. Mechanisms of pain in arthritis. Ann NY Acad Sci 966 (2002) 343-354
25. Souza D.G., Bertini R., Vieira A.T., Cunha F.Q., Poole S., Allegretti M., et al. Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury. Brit J Pharmacol 143 (2004) 132-142
26. Taylor P.C., Williams R.O., and Maini R.N. Immunotherapy for rheumatoid arthritis. Curr Opin Immunol 13 (2001) 611-616
27. Teixeira M.M., Talvani A., Tafuri W.L., Lukacs N.W., and Hellewell P.G. Eosinophil recruitment into sites of delayed-type hypersensitivity reactions in mice. J Leukoc Biol 69 (2001) 353-360
28. Ting E., Guerrero A.T., Cunha T.M., Verri Jr. W.A., Taylor S.M., Woodruff T.M., et al. Role of complement C5a in mechanical inflammatory hypernociception: potential use of C5a receptor antagonists to control inflammatory pain. Brit J Pharmacol 153 (2008) 1043-1053
29. B receptors in a morphine-sensitive manner. J Pharmacol Exp Ther 310 (2004) 710-717
30. Verri Jr. W.A., Cunha T.M., Parada C.A., Poole S., Cunha F.Q., and Ferreira S.H. Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development?. Pharmacol Ther 112 (2006) 116-138
31. Verri Jr. W.A., Cunha T.M., Parada C.A., Wei X.Q., Ferreira S.H., Liew F.Y., et al. IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin. Proc Natl Acad Sci USA 103 (2006) 9721-9725
32. Verri Jr. W.A., Cunha T.M., Parada C.A., Poole S., Liew F.Y., Ferreira S.H., et al. Antigen-induced inflammatory mechanical hypernociception in mice is mediated by IL-18. Brain Behav Immun 21 (2007) 535-543
33. Williams R.O., Feldmann M., and Maini R.N. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 89 (1992) 9784-9788
34. Woodruff T.M., Strachan A.J., Dryburgh N., Shiels I.A., Reid R.C., Fairlie D.P., et al. Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat. Arthritis Rheum 46 (2002) 2476-2485
35. Yu J.J., and Gaffen S.L. Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity. Front Biosci. 13 (2008) 170-177
36. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110